Hermetica Superfood Encyclopedia
The Short Answer
Pueraria mirifica is a Thai medicinal plant containing phytoestrogens including miroestrol and deoxymiroestrol that bind to estrogen receptors. It primarily supports menopausal symptoms by providing estrogenic activity through selective estrogen receptor modulation.
CategoryHerbs (Global Traditional)
GroupTraditional Chinese Medicine
Evidence LevelModerate
Primary KeywordPueraria mirifica benefits
Synergy Pairings5
Pueraria (Pueraria mirifica) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Pueraria mirifica is a tropical herb native to Thailand and Southeast Asia, belonging to the legume family (Fabaceae), traditionally sourced from the plant's tuberous roots. The active compounds are extracted via solvent extraction or processed into capsules as phytoestrogen-rich powders or standardized extracts containing miroestrol and deoxymiroestrol.
“In Thai traditional medicine, Pueraria mirifica (known as Kwao Keur Kao) has been used for centuries for rejuvenation and alleviating menopausal symptoms. Historical use in Southeast Asian herbal systems focused on treating estrogen deficiency-related issues like vaginal atrophy.”Traditional Medicine
Scientific Research
A randomized, double-blind, placebo-controlled trial (n=71 postmenopausal women) tested 20-50mg daily for 24 weeks, showing improved vaginal health markers without significant adverse effects (PMID: 17415017). A systematic review of 8 studies (n=309) found ~50% reduction in climacteric scores but noted methodological flaws and lack of standardization (PMID: 29409850). Small open-label studies showed climacteric score reductions from 44.1 to 11.1 over 6 months (PMID: 17710964).
Preparation & Dosage
Traditional preparation
Clinically studied doses include 20-50mg capsules daily for 24 weeks in postmenopausal women. Studies lack standardization details for active compound content. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Pueraria mirifica is a tuberous root plant whose nutritional composition is secondary in importance to its concentrated phytoestrogenic bioactive compounds. Macronutrient breakdown of the dried root powder is approximately: carbohydrates 60-70% (primarily starch and dietary fiber), protein 8-12%, fat 1-3%, moisture 8-10%. Dietary fiber content is approximately 15-20g per 100g dried root. The defining bioactive constituents are phytoestrogens, particularly the unique chromene-type miroestrol and deoxymiroestrol (estimated 0.01-0.1% dry weight), which exhibit estrogenic potency reportedly 3,000-fold greater than soy isoflavones on a molar basis. Isoflavones present include puerarin (daidzein-8-C-glucoside, ~0.5-2.0% dry weight), daidzein (~0.1-0.5%), genistein (trace amounts), and kwakhurin. Coumestans include coumestrol (0.05-0.2%). Additional phytochemicals include spinasterol, campesterol, stigmasterol (plant sterols, ~0.1-0.3%), and mirificin (a pterocarpan glycoside). Micronutrient data is limited but the root contains moderate potassium (~400-600mg/100g dry weight), calcium (~80-120mg/100g), magnesium (~30-50mg/100g), and trace iron and zinc. Bioavailability notes: miroestrol and deoxymiroestrol undergo hepatic first-pass metabolism; isoflavone bioavailability is gut-microbiome dependent with equol-producer status significantly affecting estrogenic activity; standardized extracts typically normalized to 20-50mg isoflavones per dose used in clinical studies.
How It Works
Mechanism of Action
Pueraria mirifica's bioactive compounds miroestrol and deoxymiroestrol act as selective estrogen receptor modulators (SERMs), binding to both ERα and ERβ receptors. These phytoestrogens mimic endogenous estradiol, activating estrogen-responsive pathways in target tissues including vaginal epithelium. The isoflavones genistein and daidzein provide additional weak estrogenic activity through competitive receptor binding.
Clinical Evidence
A randomized controlled trial (n=71) demonstrated that Pueraria mirifica significantly reduced vaginal dryness and dyspareunia in postmenopausal women. The study showed improvement in vaginal maturation index, with superficial cells increasing from 11% to 24% while parabasal cells decreased from 46% to 11%. Evidence for climacteric symptom relief exists but requires larger clinical trials for definitive conclusions. Current research is limited by small sample sizes and short study durations.
Safety & Interactions
Pueraria mirifica may cause estrogen-related side effects including breast tenderness, spotting, and nausea in some users. It may interact with hormone replacement therapy and estrogen-sensitive medications by potentiating estrogenic effects. Women with hormone-sensitive conditions such as breast cancer, endometriosis, or uterine fibroids should avoid use. Safety during pregnancy and breastfeeding has not been established, making it contraindicated in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pueraria mirificaKwao Keur KaoWhite Kwao KruaThai KudzuMiracle RootButea superba (related species)PM Extract
Frequently Asked Questions
How long does Pueraria mirifica take to work for menopausal symptoms
Clinical studies show improvements in vaginal dryness and maturation within 12 weeks of daily supplementation. The RCT demonstrating efficacy used a 12-week treatment period with measurable changes in vaginal epithelium occurring by study completion.
What is the effective dosage of Pueraria mirifica for menopause
The clinically studied dose for menopausal symptoms is typically 20-50mg of standardized extract daily. Higher doses up to 100mg have been used but may increase risk of estrogenic side effects without additional benefits.
Can Pueraria mirifica cause breast cancer like estrogen
While Pueraria mirifica contains phytoestrogens that bind estrogen receptors, its cancer risk profile differs from synthetic estrogens. However, women with estrogen-sensitive cancers should avoid it due to potential tumor stimulation through estrogenic pathways.
Is Pueraria mirifica better than soy isoflavones for menopause
Pueraria mirifica contains more potent phytoestrogens (miroestrol, deoxymiroestrol) than soy isoflavones, showing stronger estrogenic activity in clinical studies. The vaginal maturation improvements seen with Pueraria mirifica exceed those typically reported with soy supplementation.
What are the side effects of taking Pueraria mirifica supplements
Common side effects include breast tenderness, vaginal spotting, nausea, and headaches due to estrogenic activity. Some users report mood changes and bloating, particularly when starting supplementation or using higher doses above 50mg daily.
Does Pueraria mirifica interact with hormone replacement therapy (HRT)?
Pueraria mirifica contains phytoestrogens that may have additive estrogenic effects when combined with HRT, potentially increasing the risk of hormone-related side effects. It is important to consult with a healthcare provider before taking Pueraria mirifica if you are currently using HRT, as dose adjustments or monitoring may be necessary. Combined use has not been extensively studied in clinical trials, so professional medical guidance is recommended.
Who should avoid Pueraria mirifica supplementation?
Women with a personal or family history of hormone-sensitive cancers (breast, ovarian, or endometrial) should avoid Pueraria mirifica without medical supervision, as its phytoestrogen content may stimulate estrogen-dependent tissues. Pregnant and breastfeeding women should not use this supplement due to insufficient safety data in these populations. Individuals taking tamoxifen or other hormonal medications should consult their healthcare provider before supplementing.
Is there clinical evidence that Pueraria mirifica improves vaginal health specifically?
Yes, moderate clinical evidence from a randomized controlled trial (n=71) demonstrated that Pueraria mirifica significantly reduces vaginal dryness and dyspareunia in postmenopausal women. The same study showed measurable improvements in vaginal maturation index, with a shift from 46:43:11 to 11:65:24 in the ratio of parabasal, intermediate, and superficial cells, indicating improved vaginal epithelial health. These findings suggest Pueraria mirifica may be more targeted for vaginal symptoms than systemic menopausal relief.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pueraria curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
